Company intelligence / Profile preview
TrimmunoTec
Würzburg, Bavaria, Germanytrimmunotec.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
TrimmunoTec is a German biotechnology company focused on developing next-generation immunotherapies by targeting TNF receptors. Leveraging its proprietary bio-engineering platform, the company designs highly selective and safe TNF receptor agonists, including TNFR2, TNFR1, and CD40 agonists. Its lead program, TriTec-001, is a hexavalent single-domain antibody-based TNFR2 agonist being prepared for clinical trials in graft-versus-host disease (GvHD) prophylaxis. TrimmunoTec's pipeline also includes conditional multispecific agonists designed to selectively activate immune responses within the tumor microenvironment, minimizing systemic toxicity.
- Therapeutic areas
- ImmunologyOncology
- Modalities
- AntibodyBiologicNanobody therapyRecombinant fusion proteinBispecific monoclonal antibodyMultispecific antibody
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on TrimmunoTec.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TrimmunoTec.